ArticleCancers2024

Adverse Events of Radioligand Therapy in Patients with Progressive Neuroendocrine Neoplasms: The Biggest Eastern European Prospective Study.

Adam Daniel Durma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.